Recent News

• 03.26.2026 - Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity
• 03.26.2026 - Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity
• 03.26.2026 - Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity
• 11.21.2025 - Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants
• 11.21.2025 - Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants

Recent Filings

• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.13.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.13.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.07.2026 - 4 Statement of changes in beneficial ownership of securities